Moreover, it has been found that in GC and CRC, the expression of PRSS56 was positively correlated with the methylation level of gene body CpG sites and negatively associated with the methylation level of the CpG sites in promoter DNA. The gene discussed is PRSS56; the disease is colorectal carcinoma.